|
Reconstructive treatments for facial lipodystrophy syndrome (FLS) are reasonable, medically necessary, and appropriate for patients with HIV/AIDS who have or are undergoing antiretroviral therapy (ART), HIVMA said in a comment letter to the Centers for Medicare and Medicaid Services (CMS). CMS recently opened its national coverage determination process on Medicare coverage for the treatment. CMS plans to issue a proposed decision by July 2009 and a final decision by October 2009.
< Previous Article | Next Article >
|
